Strong Financial Outlook and Strategic Initiatives Underpin Buy Rating for AbbVie
Agilent Technologies Analyst Ratings
Agilent Technologies Analyst Ratings
Evercore ISI Adjusts Price Target on Agilent Technologies to $126 From $145
Deutsche Bank Adjusts Waters Price Target to $330 From $304
Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Aerovate Therapeutics (AVTE)
AbbVie Analyst Ratings
Buy Rating Affirmed: AbbVie's Promising Growth Trajectory and Financial Outlook
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)
Mettler-Toledo Intl Analyst Ratings
Stifel Adjusts Price Target on Mettler-Toledo International to $1,510 From $1,270
Nephron Research Raises Price Target on Mettler-Toledo International to $1,300 From $1,200
Waters Corporation: Hold Rating Affirmed Amidst Mixed Q1 Performance and Cautious Outlook
Stifel Nicolaus Sticks to Their Hold Rating for Waters (WAT)
Barclays Maintains Underweight on Waters, Lowers Price Target to $295
TD Cowen Maintains Hold on Waters, Raises Price Target to $358
Waters Analyst Ratings
Stifel Maintains Hold on Waters, Raises Price Target to $332
Bernstein Adjusts Price Target on Waters to $307 From $304
Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190